6.3
[]. Elder DP, et al. Pharmaceutical excipients - quality, regulatory and biopharmaceutical considerations. Eur J Pharm Sci. 6 May 5;87:88-99.
[]. Alessio Innocenti, et al. Carbonic anhydrase inhibitors. Inhibition of the beta-class enzymes from the fungal pathogens Candida albicans and Cryptococcus neoformans with aliphatic and aromatic carboxylates. Bioorg Med Chem. 9 Apr ;7(7):654-7.
[3]. Alessio Innocenti, et al. Carbonic anhydrase inhibitors. Interaction of isozymes I, II, IV, V, and IX with carboxylates. Bioorg Med Chem Lett. 5 Feb ;5(3):573-8.
[4]. Denis Fourches, et al. Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chem Res Toxicol. Jan;3():7-83.
[5]. Fabrizio Carta, et al. Carbonic anhydrase inhibitors. Inhibition of the β-class enzymes from the fungal pathogens Candida albicans and Cryptococcus neoformans with branched aliphatic/aromatic carboxylates and their derivatives. Bioorg Med Chem Lett. Apr 5;(8):5-6.
H3-H35-H39-H335
P6-P64-P7-P7-P8-P3+P35-P34+P34-P35+P35+P338-P33-P36+P364-P43+P33-P45-P5
GHS7
![]()
![]()